Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis

Ítems similars

• Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis
  per: Peter P. Toth, et al.
  Publicat: (2019-09-01)
• High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk
  per: Toth, Peter P., et al.
  Publicat: (2018)
• Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200–499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated Patients
  per: Toth, Peter P, et al.
  Publicat: (2019)
• Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high‐risk statin‐treated patients: A large administrative retrospective analysis
  per: Toth, Peter P., et al.
  Publicat: (2019)
• Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study)
  per: R. G. Oganov, et al.
  Publicat: (2012-08-01)